参考文献/References:
[1] 马军,秦叔逵,吴一龙,等.肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版)[J].中国肿瘤临床,2019,46(13):653-660.
[2] CROUS-BOU M,HARRINGTON L,KABRHEL C.Environmental and genetic risk factors associated with venous thromboembolism[J].Seminars in Thrombosis & Hemostasis,2016,42(8):808-820.
[3] BAKHSH E.The benefits and imperative of venous thromboembolism risk screening for hospitalized patients:A systematic review[J].Journal of Clinical Medicine,2023,12(22):709-712.
[4] 熊明秀,张静.肿瘤驱动基因与静脉血栓栓塞关系研究进展[J].实用心脑肺血管病杂志,2024,32(3):123-127.
[5] 王学智,张斌,赖全友,等.肝癌切除术后检测D-二聚体及纤维蛋白原降解产物变化对深静脉血栓形成预防意义研究[J].陕西医学杂志,2018,47(8):980-983.
[6] DANIELE P,MARIA V C,SILVIA M,et al.A comprehensive review of risk factors for venous thromboembolism:From epidemiology to pathophysiology[J].International Journal of Molecular Sciences,2023,24(4):169-173.
[7] 黄玲,傅德杰,邓姝.全膝关节置换术后深静脉血栓形成机制、危险因素及预防研究进展[J].陕西医学杂志,2024,53(3):428-432.
[8] LU Z,WANG F,LIANG M.SerpinC1/antithrombin Ⅲ in kidney-related diseases[J].Clinical Science(Lond),2017,131(9):823-831.
[9] XU D,WU J,DONG L,et al.Serpinc1 acts as a tumor suppressor in hepatocellular carcinoma through inducing apoptosis and blocking macrophage polarization in an ubiquitin-proteasome manner[J].Frontiers in Oncology,2021,11:738607.
[10] ZHOU K,ZHANG J,ZHENG Z R,et al.Diagnostic and prognostic value of TAT,PIC,TM,and t-PAIC in malignant tumor patients with venous thrombosis[J].Clinical and Applied Thrombosis/Hemostasis,2020,26:1076029620971041.
[11] KIM S,LEE W J,MOON J,et al.Utility of the SERPINC1 gene test in ischemic stroke patients with antithrombin deficiency[J].Front Neurol,2022,13:841934.
[12] WANG Y W,HUO L L,HUANG Z Y,et al.Research progress on MTHFR C677T and A1298C gene polymorphisms and gastrointestinal tumors[J].Journal of Biosciences and Medicines,2023,11(6):148-160.
[13] PETRONE I,BERNARDO P S,DOS-SANTOS E C,et al.MTHFR C677T and A1298C polymorphisms in breast cancer,gliomas and gastric cancer:A review[J].Genes(Basel),2021,12(4):587-590.
[14] SAMII A,ASLANI S,IMANI D,et al.MTHFR gene polymorphisms and susceptibility to myocardial infarction:Evidence from meta-analysis and trial sequential analysis[J].IJC Heart & Vasculature,2023,49:101293.
[15] 余晴,方宝枝,吕明恩.遗传性易栓症基因诊断的研究进展[J].实用临床医药杂志,2022,26(21):140-143.
[16] 杨旭虎,徐伍,刘建成,等.易栓症分子遗传学研究进展[J].陕西医学杂志,2023,52(10):1442-1445.
[17] 唐仪,骆珍玉,方主亭,等.MTHFR基因多态性与深静脉血栓形成及血瘀积分的相关性分析[J].中西医结合心脑血管病杂志,2019,17(12):1775-1780.
[18] 潘秀锋,李付广,李敏婷,等.MTHFR(C677T)基因多态性和同型半胱氨酸与急性脑梗死患者静脉血栓形成的相关性研究[J].检验医学与临床,2023,20(23):3480-3484.
[19] LUPI-HERRERA E,SOTO-LÓPEZ M E,LUGO-DIMAS A J,et al.Polymorphisms C677T and A1298C of MTHFR gene:Homocysteine levels and prothrombotic biomarkers in coronary and pulmonary thromboembolic disease[J].Clinical and Applied Thrombosis/Hemostasis,2019,25:1076029618780344.
[20] OSADNIK T,PAWLAS N,LEJAWA M,et al.Genetic and environmental factors associated with homocysteine concentrations in a population of healthy young adults.Analysis of the MAGNETIC study[J].Nutrition Metabolism and Cardiovascular Diseases,2020,30(6):939-947.
[21] ZENG J,ZENG Q.Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism:A meta-analysis of 99 genetic association studies[J].European Journal of Preventive Cardiology,2019,26(2):120-134.
[22] GAO M,FENG N,ZHANG M,et al.Meta analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian[J].Bioscience Reports,2020,40(7):202-206.
[23] ZHANG P,GAO X,ZHANG Y,et al.Association between MTHFR C677T polymorphism and venous thromboembolism risk in the Chinese population:A meta-analysis of 24 case-controlled studies[J].Angiology,2015,66(5):422-432.
[24] KEY N S,KHORANA A A,KUDERER N M,et al.Venous thromboembolism prophylaxis and treatment in patients with cancer:ASCO clinical practice guideline update[J].Clinical Oncology,2020,38(5):496-520.
[25] 周伟君,霍少川,蔡迎峰,等.益气活血通络汤联合阿司匹林预防人工髋关节置换术后深静脉血栓形成临床研究[J].陕西中医,2020,41(8):1070-1073.
[26] 蒋守涛,吴永刚,叶少强,等.通阳宽胸方联合PCI治疗急性心肌梗死疗效及对患者血管内皮功能的影响[J].陕西中医,2020,41(7):871-874.